News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Parkinson David Ross
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/05/2023 |
4
| Parkinson David Ross (CEO) has filed a Form 4 on ESSA Pharma Inc.|
Txns:
| Bought 21,367 shares
@ $2.39, valued at
$51.1k
Bought 3,067 shares
@ $2.6, valued at
$8k
|
|
| 07/05/2022 |
4
| Parkinson David Ross (CEO) has filed a Form 4 on ESSA Pharma Inc.|
Txns:
| Bought 4,887 shares
@ $2.958, valued at
$14.5k
|
|
| 03/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/01/2020 |
3
| Parkinson David Ross (CEO) has filed a Form 3 on ESSA Pharma Inc. |
| 03/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2019 |
4
| Parkinson David Ross (Director) has filed a Form 4 on Tocagen Inc|
Txns:
| Granted 7,500 options to buy
@ $0.6391, valued at
$4.8k
|
|
| 05/31/2019 |
4
| Parkinson David Ross (Director) has filed a Form 4 on Tocagen Inc|
Txns:
| Granted 20,000 options to buy
@ $4.22, valued at
$84.4k
|
|
| 05/20/2019 |
4
| Parkinson David Ross (Director) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Granted 120,000 options to buy
@ $0.8411, valued at
$100.9k
|
|
| 06/25/2018 |
4
| Parkinson David Ross (Director) has filed a Form 4 on Tocagen Inc|
Txns:
| Granted 20,000 options to buy
@ $8.98, valued at
$179.6k
|
|
| 05/17/2018 |
4
| Parkinson David Ross (Director) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Granted 60,000 options to buy
@ $4.61, valued at
$276.6k
|
|
| 06/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/07/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 04/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/12/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 01/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/20/2016 |
4
| Parkinson David Ross (Director) has filed a Form 4 on Cerulean Pharma Inc.|
Txns:
| Granted 12,254 shares
@ $1.02, valued at
$12.5k
|
|
| 06/28/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/24/2016 |
4
| Parkinson David Ross (Director) has filed a Form 4 on Cerulean Pharma Inc.|
Txns:
| Granted 20,000 options to buy
@ $2.08, valued at
$41.6k
|
|
| 07/06/2015 |
4
| Parkinson David Ross (Director) has filed a Form 4 on THRESHOLD PHARMACEUTICALS INC|
Txns:
| Granted 20,000 options to buy
@ $3.87, valued at
$77.4k
|
|
| 06/30/2015 |
4
| Parkinson David Ross (Director) has filed a Form 4 on Cerulean Pharma Inc.|
Txns:
| Granted 7,000 options to buy
@ $4.78, valued at
$33.5k
Granted 11,000 options to buy
@ $4.78, valued at
$52.6k
|
|
| 11/13/2014 |
4
| Parkinson David Ross (Director) has filed a Form 4 on AMBIT BIOSCIENCES CORP|
Txns:
| Disposed/sold 7,085 options to buy
@ $6.66, valued at
$47.2k
Disposed/sold 8,000 options to buy
@ $6.33, valued at
$50.6k
|
|
| 10/31/2014 |
4
| Parkinson David Ross (Director) has filed a Form 4 on Cerulean Pharma Inc.|
Txns:
| Granted 15,000 options to buy
@ $4.36, valued at
$65.4k
|
|
| 05/19/2014 |
4
| Parkinson David Ross (Director) has filed a Form 4 on THRESHOLD PHARMACEUTICALS INC|
Txns:
| Granted 20,000 options to buy
@ $3.62, valued at
$72.4k
|
|
| 05/16/2014 |
4
| Parkinson David Ross (Director) has filed a Form 4 on AMBIT BIOSCIENCES CORP|
Txns:
| Granted 8,000 options to buy
@ $6.33, valued at
$50.6k
|
|
| 05/21/2013 |
4
| Parkinson David Ross (Director) has filed a Form 4 on AMBIT BIOSCIENCES CORP|
Txns:
| Granted 7,085 options to buy
@ $6.66, valued at
$47.2k
|
|
| 05/20/2013 |
4
| Parkinson David Ross (Director) has filed a Form 4 on THRESHOLD PHARMACEUTICALS INC|
Txns:
| Granted 20,000 options to buy
@ $5.57, valued at
$111.4k
|
|
| 05/21/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/08/2011 |
4
| Parkinson David Ross (Director) has filed a Form 4 on THRESHOLD PHARMACEUTICALS INC|
Txns:
| Granted 12,500 options to buy
@ $1.64, valued at
$20.5k
|
|
| 06/01/2010 |
3
| Parkinson David Ross (Director) has filed a Form 3 on THRESHOLD PHARMACEUTICALS INC |
| 04/23/2010 |
4
| Parkinson David Ross (Director) has filed a Form 4 on FACET BIOTECH CORP|
Txns:
| Disposed/sold 2,500 shares
@ $27, valued at
$67.5k
Disposed/sold 16,667 options to buy
@ $6.17, valued at
$102.8k
Disposed/sold 5,000 options to buy
@ $9.56, valued at
$47.8k
|
|
| 04/21/2010 |
4
| Parkinson David Ross (Director) has filed a Form 4 on FACET BIOTECH CORP|
Txns:
| Unknown transaction of 8,333 shares
@ $27, valued at
$225k
|
|
| 05/28/2009 |
4
| Parkinson David Ross (Director) has filed a Form 4 on FACET BIOTECH CORP |
|
|
|